Translocation t(1;22)(p13;q13) is associated with a peculiar subtype of acute megakaryocytic leukemia (M7) occurring in infants. We have recently characterized a fusion gene, OTT-MAL, resulting from this translocation. We now report three additional cases and show that this gene fusion is present in all five t(1;22) cases studied to date. Nucleotide sequence analysis of two translocation breakpoints suggests a nonhomologous end joining mechanism in the genesis of this translocation and reveals a noncanonical topoisomerase II-like consensus sequence within the OTT gene. FISH and PCR techniques described in this work are useful for identifying t(1;22) associated with M7.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/gcc.1208 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes.
BMB Rep
December 2013
Alteogen Inc., Bioventure Town, Daejeon 305-812; Department of Biotechnology, Hannam University, Daejeon 305-811, Korea
Glucagon like peptide-1 (GLP-1) regulates glucose mediated-insulin secretion, nutrient accumulation, and β-cell growth. Despite the potential therapeutic usage for type 2 diabetes (T2D), GLP-1 has a short half-life in vivo (t(1/2) <2 min). In an attempt to prolong half-life, GLP-1 fusion proteins were genetically engineered: GLP-1 human serum albumin fusion (GLP-1/HSA), AGLP-1/HSA which has an additional alanine at the N-terminus of GLP-1, and AGLP-1-L/HSA, in which a peptide linker is inserted between AGLP-1 and HSA.
View Article and Find Full Text PDFAdenosine A(1) receptor agonist N(6)-cyclohexyl-adenosine induced phosphorylation of delta opioid receptor and desensitization of its signaling.
Acta Pharmacol Sin
July 2010
Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China.
Aim: To define the effect of adenosine A(1) receptor (A(1)R) on delta opioid receptor (DOR)-mediated signal transduction.
Methods: CHO cells stably expressing HA-tagged A(1)R and DOR-CFP fusion protein were used. The localization of receptors was observed using confocal microscope.
Preparation and characterization of a novel exendin-4 human serum albumin fusion protein expressed in Pichia pastoris.
J Pept Sci
May 2008
Department of Cell Biology, School of Medicine, Zhejiang University, Hangzhou, China.
A novel recombinant exendin-4 human serum albumin fusion protein (rEx-4/HSA) expressed in Pichia pastoris was prepared and characterized. Ex-4 is a 39-amino acid peptide isolated from the salivary gland of the lizard Heloderma suspectum and is thought to be a novel therapeutic agent for type 2 diabetes. But to gain a continued effect, the peptide has to be injected twice a day owing to its short plasma half-life (t(1/2) = 2.
View Article and Find Full Text PDFEnhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein.
Mol Cancer Ther
June 2005
Department of Medicine, Hematology-Oncology, University of Miami School of Medicine and Sylvester Comprehensive Cancer Center, FL 33136, USA.
Article Synopsis
- Endostatin inhibits angiogenesis and tumor growth, but its short serum half-life limits its effectiveness in human treatments, requiring frequent dosing.
- To address this, researchers created an antibody-endostatin fusion protein (anti-HER2 IgG3-endostatin) which has a significantly longer half-life and better targeting capabilities for HER2-positive tumors.
- The fusion protein showed greater efficacy in inhibiting tumor growth compared to regular endostatin and other treatments, suggesting that linking antiangiogenic proteins to targeting antibodies could improve cancer therapy.
PEGylation of yeast cytosine deaminase for pretargeting.
J Pharm Sci
June 2005
Division of Pharmaceutical Sciences, School of Pharmacy, University of Wisconsin-Madison, 777 Highland Avenue, Madison, WI 53705-2222, USA.
Yeast cytosine deaminase (yCD) was cloned, expressed, and purified by affinity chromatography. We have characterized the products resulting from covalent attachment of 2-4 PEG chains on yCD and determined the major and minor isomers for each respective conjugate. The results show that for non-covalently associated homodimers, it is possible to characterize and deduce PEGylation levels on individual subunits through the concurrent use of size exclusion chromatography (SEC), MALDI-TOF MS, and SDS-PAGE gels.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!